GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Panacea Life Sciences Holdings PLSH · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.07

—

Close of 6 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Panacea Life Sciences Holdings

From its filings with the US Securities and Exchange Commission

SEC filings

Panacea Life Sciences Holdings is based in Greenwood Village, Colorado and is incorporated in Nevada. Its shares trade on OTC under the ticker PLSH. The SEC classifies its business as medicinal chemicals & botanical products. In the fiscal year to 31 December 2023, it reported revenue of $2.4m and a net loss of $8.0m. At that date it held total assets of $18.0m and shareholders' equity of −$8.3m.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
24 Nov 2015
Employees
19
Head office
5910 SOUTH UNIVERSITY BLVD, GREENWOOD VILLAGE, CO, 80121
Incorporated in
NV
Classification
Medicinal Chemicals & Botanical Products
Filer status
<br>Emerging growth company

Leadership

Pay as last reported

  • Ms. Leslie ButtorffChairman of the Board, Chief Executive Officer, Chief Financial Officer, since 2021$760,000
  • Mr. Nick CavarraPresident, since 2019
  • Mr. Nathan BermanController
  • Mr. Lawrence WertIndependent Director, since 2020$300,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Panacea Life Sciences Holdings Inc employs 19 full-time employees in Greenwood Village, Colorado.
  • The company operates a 51,000-square-foot cGMP facility in Golden, Colorado for manufacturing.
  • Panacea offers branded product lines including PANA Health, PANA Beauty, and PANA Pet for consumers.

Weaknesses

  • The company has only eight retail locations in Tampa, Florida, limiting market reach.
  • Panacea Life Sciences Inc. (PLS) focuses on nutraceutical and cannabinoid products with limited diversification.
  • The firm's IPO on 24 November 2015 indicates a relatively young market presence.

Opportunities

  • White-label licensing services provide growth potential for retail businesses and CBD companies.
  • The natural health and wellness market segment offers expanding opportunities for Panacea's products.
  • Panacea's subsidiary PLS can leverage mushroom and kratom ingredients for new product development.

Threats

  • The company's reliance on hemp-derived cannabinoid products faces regulatory challenges in the US.
  • Competition in the CBD market may intensify with new entrants and established brands.
  • The firm's small employee count of 19 may hinder rapid scaling and innovation.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.